Wells Fargo’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $29.9K | Sell |
7,543
-3,334
| -31% | -$13.2K | ﹤0.01% | 5243 |
|
2025
Q1 | $75.9K | Buy |
10,877
+122
| +1% | +$852 | ﹤0.01% | 4789 |
|
2024
Q4 | $158K | Buy |
10,755
+8,684
| +419% | +$127K | ﹤0.01% | 4448 |
|
2024
Q3 | $39.6K | Sell |
2,071
-477
| -19% | -$9.13K | ﹤0.01% | 5026 |
|
2024
Q2 | $44.9K | Buy |
+2,548
| New | +$44.9K | ﹤0.01% | 4976 |
|